• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种雌激素受体靶向的钌配合物作为用于乳腺癌细胞的双光子光动力治疗剂。

An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.

机构信息

State Key Laboratory of Fine Chemicals, Dalian University of Technology, No. 2 Linggong Road, High-tech District, Dalian 116024, China.

出版信息

Chem Commun (Camb). 2018 Jun 21;54(51):7038-7041. doi: 10.1039/c8cc03786h.

DOI:10.1039/c8cc03786h
PMID:29873358
Abstract

In this study, we reported a tamoxifen modified Ru(ii) polypyridyl complex (Ru-tmxf) as an estrogen receptor (ER) targeted photosensitizer. Ru-tmxf displays enhanced cellular uptake and PDT efficiency toward breast cancer cells with high ER expression due to the specific targeting of tamoxifen to ER and finally localizes in lysosomes. Moreover, Ru-tmxf can be activated by two-photon excitation, generating 1O2 to damage lysosomes and result in cell death.

摘要

在这项研究中,我们报道了一种他莫昔芬修饰的 Ru(ii) 多吡啶配合物(Ru-tmxf)作为雌激素受体(ER)靶向光敏剂。由于他莫昔芬特异性靶向 ER,Ru-tmxf 显示出对高 ER 表达的乳腺癌细胞增强的细胞摄取和 PDT 效率,并最终定位于溶酶体中。此外,Ru-tmxf 可以通过双光子激发激活,产生 1O2 来破坏溶酶体并导致细胞死亡。

相似文献

1
An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.一种雌激素受体靶向的钌配合物作为用于乳腺癌细胞的双光子光动力治疗剂。
Chem Commun (Camb). 2018 Jun 21;54(51):7038-7041. doi: 10.1039/c8cc03786h.
2
A GSH-activatable ruthenium(ii)-azo photosensitizer for two-photon photodynamic therapy.一种用于双光子光动力疗法的谷胱甘肽可激活的钌(II)-偶氮光敏剂。
Chem Commun (Camb). 2017 Feb 7;53(12):1977-1980. doi: 10.1039/c6cc10330h.
3
Taurine-modified Ru(ii)-complex targets cancerous brain cells for photodynamic therapy.牛磺酸修饰的钌(II)配合物靶向癌细胞用于光动力疗法。
Chem Commun (Camb). 2017 May 30;53(44):6033-6036. doi: 10.1039/c7cc03337k.
4
Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.新型钌(ii)和铱(iii) BODIPY 染料:在体外光动力疗法中的应用研究
Photochem Photobiol Sci. 2019 Aug 1;18(8):2012-2022. doi: 10.1039/c9pp00201d. Epub 2019 Jul 8.
5
A novel ruthenium polypyridyl complex for the selective imaging and photodynamic targeting of the Golgi apparatus.一种新型钌多吡啶配合物,用于高尔基体的选择性成像和光动力靶向。
Dalton Trans. 2021 Mar 16;50(10):3536-3541. doi: 10.1039/d1dt00216c.
6
Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.钌(II)配合物作为用于针对三阴性乳腺癌细胞的肿瘤特异性光动力疗法的生物正交双光子光敏剂。
Chem Commun (Camb). 2021 May 4;57(36):4408-4411. doi: 10.1039/d1cc00661d.
7
A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy.一种具有增强的光稳定性的菁染料类光敏剂,用于线粒体靶向光动力疗法。
Chem Commun (Camb). 2019 Nov 7;55(90):13542-13545. doi: 10.1039/c9cc06157f.
8
Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.设计一种具有红光激发和显著提高的光生物活性的三齿杂配钌(II)配合物。
Inorg Chem. 2020 Aug 3;59(15):11193-11204. doi: 10.1021/acs.inorgchem.0c01860. Epub 2020 Jul 23.
9
Functionalized Eu(III)-Based Nanoscale Metal-Organic Framework To Achieve Near-IR-Triggered and -Targeted Two-Photon Absorption Photodynamic Therapy.基于功能化铕(III)的纳米级金属有机框架实现近红外触发和靶向双光子吸收光动力疗法
Inorg Chem. 2018 Jan 2;57(1):300-310. doi: 10.1021/acs.inorgchem.7b02475. Epub 2017 Dec 8.
10
Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.初步的体外抗癌光动力治疗研究与混合金属双核钌(II)-钒(IV)配合物。
Dalton Trans. 2013 Sep 7;42(33):11881-99. doi: 10.1039/c3dt50547b.

引用本文的文献

1
Polymeric Nanoparticle-Mediated Photodynamic Therapy: A Synergistic Approach for Glioblastoma Treatment.聚合物纳米颗粒介导的光动力疗法:一种用于胶质母细胞瘤治疗的协同方法。
Pharmaceuticals (Basel). 2025 Jul 18;18(7):1057. doi: 10.3390/ph18071057.
2
Photodynamic therapy in brain cancer: mechanisms, clinical and preclinical studies and therapeutic challenges.脑癌中的光动力疗法:作用机制、临床及临床前研究与治疗挑战
Front Chem. 2023 Nov 24;11:1250621. doi: 10.3389/fchem.2023.1250621. eCollection 2023.
3
Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy.
用于肿瘤靶向抗癌治疗的钌(II)多吡啶配合物的封装
BME Front. 2023 Aug 1;4:0024. doi: 10.34133/bmef.0024. eCollection 2023.
4
Exploring the Anticancer Activity of Tamoxifen-Based Metal Complexes Targeting Mitochondria.探讨基于他莫昔芬的靶向线粒体的金属配合物的抗癌活性。
J Med Chem. 2023 Jul 27;66(14):9823-9841. doi: 10.1021/acs.jmedchem.3c00617. Epub 2023 Jul 6.
5
Cancer Cell-Specific Fluorescent Prodrug Delivery Platforms.癌细胞特异性荧光前药递药平台。
Adv Sci (Weinh). 2023 Jun;10(16):e2207768. doi: 10.1002/advs.202207768. Epub 2023 Apr 7.
6
Advances in the Development of Prodrugs as Selective Modulators of Estrogen Receptors.前药作为雌激素受体选择性调节剂的研发进展
J Endocr Soc. 2022 Oct 19;6(12):bvac158. doi: 10.1210/jendso/bvac158. eCollection 2022 Oct 26.
7
Photodynamic therapy in breast cancer treatment.光动力疗法在乳腺癌治疗中的应用。
J Appl Biomed. 2022 Oct;20(3):98-105. doi: 10.32725/jab.2022.013. Epub 2022 Oct 4.
8
Vitamin D and Vitamin D3 Supplementation during Photodynamic Therapy: A Review.维生素 D 和维生素 D3 在光动力疗法中的补充:综述。
Nutrients. 2022 Sep 15;14(18):3805. doi: 10.3390/nu14183805.
9
Evaluation of the In Vitro and In Vivo Efficacy of Ruthenium Polypyridyl Compounds against Breast Cancer.评价钌多吡啶配合物抗乳腺癌的体外和体内疗效。
Int J Mol Sci. 2021 Aug 18;22(16):8916. doi: 10.3390/ijms22168916.
10
Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells.新兴的分子受体可将钌和金配合物特异性靶向递送至癌细胞。
Molecules. 2021 May 25;26(11):3153. doi: 10.3390/molecules26113153.